peptide arrays
The company is leveraging immunogenic peptides created by cancer cells as diagnostic and vaccine targets in both humans and dogs.
HealthTell Completes $26M Series B Financing Round
The company, which also raised $14 million in a Series A round, plans to use the proceeds to commercialize panels of tests for autoimmune diseases.
Researchers used arrays with more than 175,000 peptides matching sections of the Chagas pathogen proteome to characterize novel elements of the immune response to infection.
Roche has created a new business unit to oversee the development and commercialization of sequencing- and microarray-based products.
Roche still plans to make its high-density peptide microarrays available to customers in the future.
Apr 30, 2013
Apr 26, 2013
Oct 2, 2012
Oct 2, 2012
Tecan, JPT to Co-promote Array Products
Feb 7, 2012
Mar 25, 2011
Aug 10, 2010
In Print: Aug 10, 2010
Premium
Jul 16, 2009